Literature DB >> 27418866

Evaluation of Endothelial Cell Adhesion Molecules and Anti-C1q Antibody in Discriminating between Active and Non-Active Systemic Lupus Erythematosus.

Hasni Mahayidin1, Nurul Khaiza Yahya2, Wan Syamimee Wan Ghazali3, Asmahan Mohd Ismail4, Wan Zuraida Wan Ab Hamid2.   

Abstract

BACKGROUND: Detecting the active state of systemic lupus erythematosus (SLE) is important but challenging. This study aimed to determine the diagnostic accuracy of serum endothelial cell adhesion molecules (ICAM-1 and VCAM-1) and anti-C1q antibody in discriminating between active and non-active SLE.
METHODS: Using SELENA-SLE disease activity index (SLEDAI), 95 SLE patients (45 active and 50 non-active) were assessed. A score above five was considered indicative of active SLE. The blood samples were tested for serum ICAM-1, VCAM-1 and anti-C1q antibody using enzyme-linked immunosorbent assay (ELISA).
RESULTS: The levels of serum VCAM-1 and anti-C1q antibody were significantly higher in active SLE patients. Both VCAM-1 and anti-C1q were able to discriminate between active and non-active SLE (p-value < 0.001 and 0.005, respectively). From the receiver operating characteristic curves (ROCs) constructed, the optimal cut-off values for VCAM-1 and anti-C1q antibody in discriminating between active and non-active SLE were 30.5 ng/mL (69.0% sensitivity, 60.0% specificity, PPV 58.5%, NPV 66.7%) and 7.86 U/mL (75.6% sensitivity, 80% specificity, PPV 77.3%, NPV 78.4%), respectively. However, serum ICAM-1 level was unable to discriminate between the two groups (p-value = 0.193).
CONCLUSION: Anti-C1q antibody demonstrated the best diagnostic accuracy in discriminating between active and non-active SLE patients.

Entities:  

Keywords:  anti-C1q antibody; cell adhesion molecules; intercellular adhesion molecule-1 (ICAM-1); systemic lupus erythematosus; vascular cell adhesion molecule-1 (VCAM-1)

Year:  2016        PMID: 27418866      PMCID: PMC4934715     

Source DB:  PubMed          Journal:  Malays J Med Sci        ISSN: 1394-195X


  35 in total

1.  Clinical utility of selected disease activity markers in patients with systemic lupus erythematosus.

Authors:  P Horák; V Scudla; Z Hermanovó; Z Pospisil; L Faltýnek; M Budiková; L Kusá
Journal:  Clin Rheumatol       Date:  2001       Impact factor: 2.980

2.  Soluble intercellular adhesion molecule-1 (sICAM-1) in patients with systemic lupus erythematosus.

Authors:  N Tulek; O Aydintug; K Ozoran; H Tutkak; N Duzgun; M Duman; G Tokgoz
Journal:  Clin Rheumatol       Date:  1996-01       Impact factor: 2.980

3.  Anti-C1q antibodies are associated with systemic lupus erythematosus disease activity and lupus nephritis in northeast of China.

Authors:  Cai-Qin Zhang; Lei Ren; Fei Gao; Feng-Yun Mu; Yan-Qiu You; Yan-Hong Liu
Journal:  Clin Rheumatol       Date:  2011-02-23       Impact factor: 2.980

Review 4.  Assessment of disease activity in Systemic Lupus Erythematosus: Lights and shadows.

Authors:  Fulvia Ceccarelli; Carlo Perricone; Laura Massaro; Enrica Cipriano; Cristiano Alessandri; Francesca Romana Spinelli; Guido Valesini; Fabrizio Conti
Journal:  Autoimmun Rev       Date:  2015-03-02       Impact factor: 9.754

5.  Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study.

Authors:  S J Hwang; C M Ballantyne; A R Sharrett; L C Smith; C E Davis; A M Gotto; E Boerwinkle
Journal:  Circulation       Date:  1997-12-16       Impact factor: 29.690

6.  Combined oral contraceptives in women with systemic lupus erythematosus.

Authors:  Michelle Petri; Mimi Y Kim; Kenneth C Kalunian; Jennifer Grossman; Bevra H Hahn; Lisa R Sammaritano; Michael Lockshin; Joan T Merrill; H Michael Belmont; Anca D Askanase; W Joseph McCune; Michelene Hearth-Holmes; Mary Anne Dooley; Joan Von Feldt; Alan Friedman; Mark Tan; John Davis; Mary Cronin; Betty Diamond; Meggan Mackay; Lisa Sigler; Michael Fillius; Ann Rupel; Frederick Licciardi; Jill P Buyon
Journal:  N Engl J Med       Date:  2005-12-15       Impact factor: 91.245

7.  Immunoinflammatory markers and disease activity in systemic lupus erythematosus: something old, something new.

Authors:  M A Elwy; Z A Galal; H E Hasan
Journal:  East Mediterr Health J       Date:  2010-08       Impact factor: 1.628

8.  A circadian variation exists for soluble levels of intercellular adhesion molecule-1 and E-selectin in healthy volunteers.

Authors:  C Maple; G Kirk; M McLaren; D Veale; J J Belch
Journal:  Clin Sci (Lond)       Date:  1998-05       Impact factor: 6.124

9.  Anti-C1q antibodies and systemic lupus erythematosus in the Tunisian population.

Authors:  B Trad; H Ben Hassine; M Khalifa; N Idriss; F Slama; F Bahri; C Laouani Kechrid; J Boukadida; R Sghiri
Journal:  Pathol Biol (Paris)       Date:  2013-02-08

10.  Autoantibodies against C1q as a Diagnostic Measure of Lupus Nephritis: Systematic Review and Meta-analysis.

Authors:  Paul Eggleton; Obioha C Ukoumunne; Isabel Cottrell; Asma Khan; Sidra Maqsood; Jemma Thornes; Elizabeth Perry; David Isenberg
Journal:  J Clin Cell Immunol       Date:  2014-04-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.